Embecta Corp. (EMBC) exhibits 62.6% gross margins and 35.5% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 6.1x enterprise multiple and 4.8% implied options volatility.
Sustained 62.6% gross profitability converts into 22.4% operating margin and 35.5% ROIC, outpacing sector cost of capital.
ROIC: 35.5% // GM: 62.6%YoY revenue trajectory of -3.8% paired with 2.80% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -3.8% // FCF YLD: 2.80%Altman Z-Score of 3.80 and Piotroski F-Score of 7/9 indicate low near-term refinancing stress.
ALTMAN Z: 3.80 // F-SCORE: 7/9Trading at 3.9x trailing P/E (3.6x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 3.9x // EV/EBITDA: 6.1xOptions market prices a ±5.2% implied move with a 0.85 put/call ratio around $6.56 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 8.8% net margins.
NET MARGIN: 8.8% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for EMBC & activate live FRED threshold breach alerts.